RPCEC00000224招募中1 期
Active specific immunotherapy with the vaccine preparation NGcGM3 / VSSP in patients with small cell lung cancer
Center of Molecular Immunology (CIM)0 个研究点目标入组 40 人开始时间: 2016年12月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment
入排标准
- 年龄范围
- 18 years 至 one（—）
- 性别
- All
入选标准
- •1.Patients with measurable lesions by application of RECIST version 1.1.
- •2.Patients older than 18 years.
- •3.Patients who consent to participate in the study by signing the informed consent model.
- •4.Patients with ECOG scale of Performance Status = 2.
- •5.Patients with normal functioning of organs and bone marrow defined by laboratory parameters.
排除标准
- •1.Patients who have been treated with NGcGm3 / VSSP within 6 months prior to recruited.
- •2.Patients who have been included in another clinical trial within 6 months prior to recruited.
- •3.Patients who are pregnant or breastfeeding.
- •4.Patients with brain metastases.
- •5.Patients with acute or chronic infectious diseases.
- •6.Patients with a history of allergy attributed to compounds of chemical or biological composition similar to the vaccine.
- •7.Patients with autoimmune diseases.
- •8.Patients with descompensated chronic diseases.
研究者
相似试验
招募中
2 期
GcGM3/VSSP in Metastatic melanomaMetastatic melanomaNevi and MelanomasNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms, Nerve TissueMelanomaRPCEC00000223Center of Molecular Immunology (CIM)160
尚未招募
2 期
GcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancerMetastatic hormone-receptor positive and HER2 negative breast cancerBreast NeoplasmsBreast DiseasesRPCEC00000220Center of Molecular Immunology (CIM)286
已完成
2 期
1E10 anti-idiotype vaccine, metastatic colon, phase II.Colon adenocarcinoma phase IV or evolvable metastatic diseaseColonic NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesColorectal NeoplasmsRPCEC00000006Center of Molecular Immunology (CIM)40
已完成
2 期
1E10 anti-idiotype vaccine, metastatic breast cancer, phase IIBreast carcinoma in stage IV or progressive metastatic diseaseBreast NeoplasmsCarcinomaBreast DiseasesRPCEC00000008Center of Molecular Immunology (CIM)80
已完成
2 期
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patientsAdvanced Lung Cancer Non-small Cell Lung CancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesRPCEC00000009Center of Molecular Immunology (CIM)176